High dose chemotherapy (HDC) with peripheral blood stem cell (PBSC) transplantation for patients (pts) with advanced ovarian cancer.

被引:0
|
作者
Bojko, P
Hilger, R
Schenlen, ME
Oberhoff, C
Schindler, AE
Seeber, S
机构
[1] Univ Essen Gesamthsch, W German Canc Ctr, Dept Internal Med, Essen, Germany
[2] Univ Essen Gesamthsch, Dept Obstet & Gynaecol, Essen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
365P
引用
收藏
页码:82 / 82
页数:1
相关论文
共 50 条
  • [31] High-dose busulfan, melphalan and thiotepa (BUMELTT) followed by autologous peripheral blood stem cells (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
    Holmberg, LA
    Demirer, T
    Sciffman, K
    Rowley, SD
    Buckner, CD
    Goodman, G
    Maziarz, R
    Appelbaum, F
    Bensinger, WI
    BLOOD, 1997, 90 (10) : 1705 - 1705
  • [32] DICEP high dose (HD-DICEP) chemotherapy (CT) with or without peripheral blood stem cell support as consolidation treatment of patients (pts) with advanced epithelial ovarian cancer (AOC)
    Garcia-Carbonero, I
    Casado, A
    Martin, M
    Lopez-Martin, JA
    Oruezabal, M
    Nieto, Y
    Alonso, JL
    Portugal, T
    Alvarez, J
    Diaz-Rubios, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S237 - S238
  • [33] Effects of lenograstim or filgrastim on blood cell recovery after high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (PBSCT)
    Bojko, Peter
    Huettmann, Andreas
    Schirsafi, Kasra
    Seeber, Siegfried
    ANNALS OF ONCOLOGY, 2004, 15 : 223 - 223
  • [34] Dose-intensive cyclophosphamide, etoposide, and platinum (DICEP) as a priming/mobilization regimen for peripheral blood stem cell (PBSC) harvesting prior to high dose chemotherapy (HDC).
    Jennis, A
    Pecora, AL
    Isaacs, RE
    Cantwell, S
    Michelis, AM
    Zahos, K
    BLOOD, 1996, 88 (10) : 1605 - 1605
  • [35] Prolonged clinical remission in patients (pts) with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation (ABSCT).
    Castro, J
    Bentch, HL
    Smith, L
    Kalter, S
    Bachier, C
    Meneghetti, C
    Moore, A
    Oliversen, S
    LeMaistre, CF
    BLOOD, 1996, 88 (10) : 519 - 519
  • [36] Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer
    BenedettiPanici, P
    Greggi, S
    Scambia, G
    Salerno, MG
    Baiocchi, G
    Laurelli, G
    Menichella, G
    Pierelli, L
    Foddai, ML
    Serafini, R
    Bizzi, B
    Mancuso, S
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (12) : 1987 - 1992
  • [37] High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer
    Holmberg, LA
    Demirer, T
    Rowley, S
    Buckner, CD
    Goodman, G
    Maziarz, R
    Klarnet, J
    Zuckerman, N
    Harrer, G
    McCloskey, R
    Gersh, R
    Goldberg, R
    Nichols, W
    Jacobs, A
    Weiden, P
    Montgomery, P
    Rivkin, S
    Appelbaum, FR
    Bensinger, WI
    BONE MARROW TRANSPLANTATION, 1998, 22 (07) : 651 - 659
  • [38] High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer
    LA Holmberg
    T Demirer
    S Rowley
    CD Buckner
    G Goodman
    R Maziarz
    J Klarnet
    N Zuckerman
    G Harrer
    R McCloskey
    R Gersh
    R Goldberg
    W Nichols
    A Jacobs
    P Weiden
    P Montgomery
    S Rivkin
    FR Appelbaum
    WI Bensinger
    Bone Marrow Transplantation, 1998, 22 : 651 - 659
  • [39] Twin isolations after high dose chemotherapy and peripheral blood stem cell (PBSC) transplantation for high risk breast cancer: Psychological and microbiological assessment.
    Cocquio, A
    Roberta, M
    Ilaria, M
    Antonella, D
    Compare, L
    Orlando, L
    Rossetti, F
    Casellato, L
    Cocorocchio, E
    Peccatori, F
    Martinelli, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S246 - S246
  • [40] High-dose chemotherapy with peripheral blood stem cell transplantation in first-line therapy for advanced germ cell cancer
    Fujii, Y
    Saito, K
    Kawakami, S
    Masada, H
    Hyochi, N
    Yano, M
    Kageyama, Y
    Kihara, K
    JOURNAL OF UROLOGY, 2003, 169 (04): : 239 - 239